In the dynamic realm of biopharma and healthcare technology, Ivan Kairatov stands out as a seasoned expert. With extensive experience in research and development, Ivan provides a unique perspective on the innovations shaping this industry. Today, we delve into the recent performance of Hims & Hers
In an unprecedented move, President Donald Trump's fiscal strategy for 2026 proposes a staggering $18 billion reduction in health research funding from the U.S. National Institutes of Health (NIH), sending shockwaves through the academic radiology community. Researchers face intense financial
Recent legal actions by major drug manufacturers, such as Eli Lilly, highlight growing concerns over the ethics and legality associated with telehealth companies and compounding pharmacies involved in providing compounded diabetes and weight-loss medications. These developments underscore a
The integration of artificial intelligence into the realm of biological research represents a seismic shift in scientific processes and methodologies. This evolution is vividly illustrated by the experiences of Malek Elsayyid, a graduate student from the University of Delaware, whose academic
The concept that "prevention is better than cure" has been an essential directive in healthcare for centuries. This age-old wisdom finds new relevance as advances in artificial intelligence (AI) make early detection and intervention more achievable. AI technologies promise to reshape patient care
Advancements in healthcare technology have taken a significant leap forward with the introduction of Cancer 360 by the UK's National Health Service (NHS). This groundbreaking tool, designed to improve cancer diagnosis and treatment, integrates seamlessly into the federated data platform (FDP).
